SCHEMBL21476833

SCHEMBL21476833

c1ccc2cc3c(cc2c1)oc1ccc(-c2nc(-c4ccc(-c5cc6ccccc6o5)cc4)cc(-c4ccc(-c5cccc6ccccc56)cc4)n2)cc13

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.41
PTPRC P08575 1/20 0.39
PTPN1 P18031 1/20 0.39
ENPP3 O14638 1/20 0.39
ENPP1 P22413 1/20 0.39
PLA2G2A P14555 4/20 0.38
PLA2G4A P47712 4/20 0.38
PLA2G10 O15496 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
MAOA P21397 2/20 0.37
ALOX5 P09917 1/20 0.37
CCNT1 O60563 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CDK9 P50750 1/20 0.36
METAP2 P50579 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23334919 0.96 ENPP3 (0.39) MAOBPTPRCPTPN1ENPP3ENPP1
SCHEMBL21476635 0.93 MAOB (0.43) MAOBPTPRCPTPN1PLA2G2APLA2G4A
SCHEMBL21476837 0.90 MAOB (0.44) MAOBPTPRCPTPN1ENPP3ENPP1
SCHEMBL21476571 0.89 MAOB (0.41) MAOBPTPRCPTPN1PLA2G2APLA2G4A
SCHEMBL23334950 0.89 PTPRC (0.38) MAOBPTPRCPTPN1ENPP3ENPP1
SCHEMBL21476498 0.88 PLA2G2A (0.46) MAOBPTPRCPTPN1PLA2G2APLA2G4A
SCHEMBL21480655 0.86 PLA2G2A (0.46) MAOBPTPN1PLA2G2APLA2G4APLA2G10
SCHEMBL23335210 0.85 ENPP1 (0.41) MAOBPTPRCPTPN1ENPP3ENPP1
SCHEMBL22138188 0.84 PIM1 (0.41) MAOBENPP3ENPP1MAOANPC1
SCHEMBL21476678 0.83 PLA2G2A (0.45) MAOBPTPN1PLA2G2APLA2G4APLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-05-06 US disclosed
WO-2019198806-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, MLX, LEF1 MAOB 2115/4885PTPRC 4495/4885PTPN1 3475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.